Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.

PloS one·2024
Same author

Standardized bone marrow assessment, risk variables, and survival in dogs with myelodysplastic syndrome and acute myeloid leukemia.

Veterinary pathology·2024
Same author

Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy or radiation therapy or both: A retrospective observational study.

Journal of veterinary internal medicine·2024
Same author

Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma.

Veterinary and comparative oncology·2023
Same author

Prognostic significance of the urokinase plasminogen activator system in tissue and serum of dogs with appendicular osteosarcoma.

PloS one·2022
Same journal

Imaging diagnosis of intrauterine fetal death in a cat with singleton pregnancy.

Topics in companion animal medicine·2026
Same journal

Distraction osteogenesis in a juvenile rooster (Gallus gallus domesticus) with mandibular fracture malunion.

Topics in companion animal medicine·2026
Same journal

Methylation analysis of LINE-1 elements in canine cutaneous mast cell tumors.

Topics in companion animal medicine·2026
Same journal

Electrochemotherapy with carboplatin and bleomycin associated with mastectomy in cats with mammary carcinoma: A pilot study.

Topics in companion animal medicine·2026
Same journal

Solitary extramedullary plasmacytoma in the larynx of a domestic cat.

Topics in companion animal medicine·2026
Same journal

Giant mammary fibroadenoma in four female dogs.

Topics in companion animal medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Metronomic chemotherapy.

Anthony J Mutsaers1

  • 1Division of Molecular and Cell Biology, Sunnybrook Health Sciences Centre, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Anthony.Mutsaers@sri.utoronto.ca

Topics in Companion Animal Medicine
|September 8, 2009
PubMed
Summary
This summary is machine-generated.

Metronomic chemotherapy, a novel approach, involves frequent, low-dose chemotherapy administration. This method shows promise in cancer treatment by potentially inhibiting tumor growth and improving outcomes.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jun 20, 2026

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Area of Science:

  • Veterinary Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • Traditional chemotherapy uses high doses with breaks for side effect management.
  • Metronomic chemotherapy offers a continuous or near-continuous dosing schedule.
  • This approach is gaining interest for its potential benefits in cancer therapy.

Purpose of the Study:

  • To explore the principles and potential applications of metronomic chemotherapy.
  • To evaluate its efficacy, particularly in combination with other therapies.
  • To assess its suitability for veterinary oncology.

Main Methods:

  • Review of current research and preliminary clinical trial data.
  • Analysis of proposed mechanisms of action, including anti-angiogenesis and immunomodulation.
  • Examination of drug, dose, schedule, and tumor-specific optimization.

Main Results:

  • Metronomic chemotherapy may work by continuous drug exposure, inhibiting tumor angiogenesis, and altering tumor immunology.
  • Combination with targeted antiangiogenic agents shows increased benefit.
  • Preliminary trials in humans and animals show promise, including in canine cancers.

Conclusions:

  • Metronomic chemotherapy is a promising investigational approach, especially for veterinary applications, due to its potential low cost, ease of administration, and favorable toxicity.
  • Further research and larger studies are needed to optimize its use.
  • Its role in combination therapy, particularly with targeted agents, warrants continued investigation.